Latest Period
Q2 2026
Security Snapshot
Sanara MedTech Inc. - Common Stock, $0.001 par value (SMTI) Institutional Ownership
CUSIP: 79957L100
13F Institutional Holders and Ownership History from Q4 2020 to Q2 2026
Institutions Reporting
74
Shares (Excl. Options)
1,785,103
Price
$23.59
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.001 par value
- Symbol
- SMTI on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 1,785,103
- Total 13F value
- $42,118,036
- Portfolio coverage rank
- 0%
- Share change
- +307,022
- Value change
- +$7,387,354
- Number of holders
- 74
- Shares outstanding
- 8,944,624
- SEC-reported price per share
- $34.06
- Insider filing price
- $34.06
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SMTI - Sanara MedTech Inc. - Common Stock, $0.001 par value is tracked under CUSIP 79957L100.
- 74 institutions reported positions in Q2 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 65 to 74 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $25,649,814 to $42,118,036.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 74 institutions filings for Q2 2026.
Security key
79957L100
Latest holder period
Q2 2026
13F holders
74
13D/G owners
1
CIK / CUSIP context first
Open Q2 2026 holders
SMTI full holder history
Sanara MedTech Inc. SEC filings
Sanara MedTech Inc. company facts
Sanara MedTech Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 79957L100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
SMTI
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BAIRD TRUST Co | 0% | -94% | $362,290 | -$12,707,527 | 21,075 | -97% | BAIRD TRUST Co | 31 Mar 2026 |
As of 30 Jun 2026, 74 institutional investors reported holding 1,785,103 shares of Sanara MedTech Inc. - Common Stock, $0.001 par value (SMTI). This represents 20% of the company’s total 8,944,624 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
18%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2.8% | 248,827 | +8.8% | 0% | $5,869,829 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.2% | 194,897 | +29% | 0% | $4,597,620 |
| ROYAL BANK OF CANADA | 1.5% | 130,994 | -0.29% | 0% | $3,091,000 |
| Stonebridge Wealth Management, LLC | 1.4% | 129,452 | -5.4% | 2.7% | $3,053,773 |
| AQR CAPITAL MANAGEMENT LLC | 1.3% | 112,207 | +181% | 0% | $2,646,952 |
| GEODE CAPITAL MANAGEMENT, LLC | 1% | 89,179 | +4.1% | 0% | $2,104,778 |
| GOLDMAN SACHS GROUP INC | 0.83% | 74,198 | +244% | 0% | $1,750,331 |
| RENAISSANCE TECHNOLOGIES LLC | 0.75% | 67,400 | +4.2% | 0% | $1,589,966 |
| STATE STREET CORP | 0.71% | 63,469 | +1.2% | 0% | $1,497,234 |
| Squarepoint Ops LLC | 0.6% | 53,811 | -27% | 0% | $1,269,401 |
| JANE STREET GROUP, LLC | 0.57% | 50,806 | +32% | 0% | $1,198,514 |
| MARSHALL WACE, LLP | 0.55% | 49,457 | -35% | 0% | $1,166,690 |
| CITADEL ADVISORS LLC | 0.41% | 36,813 | +18% | 0% | $868,419 |
| NORTHERN TRUST CORP | 0.41% | 36,441 | +9.6% | 0% | $859,644 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.35% | 31,644 | 0% | $746,482 | |
| Walleye Capital LLC | 0.34% | 30,465 | 0% | $718,669 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 0.3% | 26,830 | 0% | $632,920 | |
| VANGUARD FIDUCIARY TRUST CO | 0.29% | 26,027 | +2.6% | 0% | $613,977 |
| Evernest Financial Advisors, LLC | 0.29% | 25,700 | 0.13% | $606,263 | |
| MORGAN STANLEY | 0.26% | 23,628 | +20% | 0% | $557,384 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.26% | 23,417 | +29% | 0% | $552,407 |
| HSBC HOLDINGS PLC | 0.26% | 23,254 | +35% | 0% | $549,725 |
| Baird Financial Group, Inc. | 0.24% | 21,075 | 0% | 0% | $497,159 |
| Qube Research & Technologies Ltd | 0.23% | 20,400 | -23% | 0% | $481,236 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.22% | 19,252 | +77% | 0% | $455,000 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
23
Latest
Q2 2026
Rows shown
1-23 of 23
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 1,785,103 | $42,118,036 | +$7,387,354 | $23.59 | 74 |
| 2026 Q1 | 1,492,653 | $25,649,814 | -$8,388,094 | $17.18 | 65 |
| 2025 Q4 | 1,935,148 | $45,190,323 | +$18,180,986 | $23.35 | 53 |
| 2025 Q3 | 1,137,683 | $36,088,261 | +$1,057,717 | $31.73 | 57 |
| 2025 Q2 | 1,106,235 | $31,408,453 | +$1,940,235 | $28.39 | 51 |
| 2025 Q1 | 916,291 | $28,277,079 | -$1,441,540 | $30.87 | 47 |
| 2024 Q4 | 952,781 | $31,629,770 | +$4,711,802 | $33.20 | 49 |
| 2024 Q3 | 810,359 | $24,503,030 | +$2,164,185 | $30.24 | 42 |
| 2024 Q2 | 730,401 | $20,613,392 | +$1,060,836 | $28.22 | 38 |
| 2024 Q1 | 679,473 | $25,138,649 | -$220,177 | $37.00 | 41 |
| 2023 Q4 | 685,113 | $28,157,833 | +$2,262,867 | $41.10 | 46 |
| 2023 Q3 | 630,117 | $19,626,710 | -$1,563,167 | $31.13 | 42 |
| 2023 Q2 | 666,943 | $26,745,074 | +$8,027,572 | $40.10 | 47 |
| 2023 Q1 | 462,617 | $19,085,507 | +$4,275,450 | $41.25 | 35 |
| 2022 Q4 | 381,841 | $17,371,120 | +$2,570,809 | $45.50 | 31 |
| 2022 Q3 | 334,830 | $9,938,000 | +$2,183,700 | $29.70 | 26 |
| 2022 Q2 | 261,136 | $5,447,000 | -$453,195 | $20.87 | 19 |
| 2022 Q1 | 275,288 | $7,787,000 | -$1,912,163 | $28.45 | 19 |
| 2021 Q4 | 341,977 | $10,175,000 | -$1,642,750 | $29.66 | 21 |
| 2021 Q3 | 382,356 | $13,067,000 | +$4,029,831 | $34.23 | 22 |
| 2021 Q2 | 268,928 | $9,723,000 | -$8,724,209 | $36.94 | 18 |
| 2021 Q1 | 557,420 | $17,214,000 | +$13,229,620 | $31.15 | 19 |
| 2020 Q4 | 104,642 | $5,198,000 | +$5,198,000 | $49.89 | 14 |